On 2/12/25, Capricor Therapeutics Inc (NASDAQ: CAPR) stock enjoyed a major increase of 11.6%, closing at $15.05. This advance was accompanied by normal trading volume. Relative to the market the stock has been exceptionally strong over the last nine months but is unchanged during the last week.
Current PriceTarget Research Rating
Capricor Therapeutics has a current Value Trend Rating of C (Low Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Capricor Therapeutics has a very low Appreciation Score of 2 but a very high Power Rating of 88, leading to the Low Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment